HC2 A Review of Economic Evaluations of New Drugs Priced by the Similar Drug Comparison Method in Japan- Did Cost-Effectveness Results Justify Premiums?
Abstract
Authors
M. Kasai T. Shiroiwa S. Ikeda
M. Kasai T. Shiroiwa S. Ikeda
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now